Valuation: IRADIMED CORPORATION

Market Cap 1.22B 1.07B 987M 920M 1.73B 116B 1.77B 11.87B 4.6B 57.01B 4.59B 4.49B 198B P/E 2026 *
50x
P/E 2027 * 44.1x
Enterprise Value 1.22B 1.07B 987M 920M 1.73B 116B 1.77B 11.87B 4.6B 57.01B 4.59B 4.49B 198B EV / Sales 2026 *
13.4x
EV / Sales 2027 * 12.1x
Free-Float
64.8%
Yield 2026 *
-
Yield 2027 * -
1 day+3.07%
1 week+4.10%
Current month+3.12%
1 month+7.05%
3 months+2.07%
6 months+3.18%
Current year+1.30%
1 week 92.04
Extreme 92.035
98.7
1 month 87.91
Extreme 87.91
98.7
Current year 76.95
Extreme 76.95
107.9
1 year 55.11
Extreme 55.1093
107.9
3 years 36.12
Extreme 36.12
107.9
5 years 26
Extreme 26
107.9
10 years 7.85
Extreme 7.85
107.9
Manager TitleAgeSince
Chief Executive Officer 72 27/05/2020
Director of Finance/CFO 64 19/06/2022
Chief Tech/Sci/R&D Officer - 31/12/2019
Director TitleAgeSince
Chairman 72 15/06/2020
Director/Board Member 70 31/12/2018
Director/Board Member 73 31/12/2013
Date Insider Type Main position Quantity % Market Cap.
06-19Fiscal year

Chief Financial Officer

13,911 0.1088%
06-03Sell

Director

-3,000 0.0235%
05-31Sell

Chief Executive Officer

-2,500 0.0196%
Change 5-day change 1-year change 3-year change Capi.($)
+3.07%+4.10%+62.85%+105.81% 1.22B
+2.62%+1.33%-18.68%-24.73% 12.22B
-0.15%+11.17%+97.86%+20.30% 5.4B
+4.51%+1.69%-35.33%-64.73% 1.17B
+3.72%-5.78%-38.66%-49.11% 1.06B
+4.37%-5.16%-43.07% - 866M
-0.29%-3.11%+171.20%+165.95% 656M
-4.02%+2.47% - - 379M
-1.96%+16.96%-53.90%+241.33% 287M
+0.37%-7.19%+97.12%-37.56% 134M
Average +1.22%+5.16%+26.60%+44.66% 2.34B
Weighted average by Cap. +1.95%+4.35%+15.98%-0.80%

Financials

2026 *2027 *
Net sales 91.2M 80.07M 73.7M 68.68M 130M 8.67B 132M 886M 343M 4.26B 342M 335M 14.81B 101M 88.59M 81.54M 75.98M 143M 9.59B 146M 981M 380M 4.71B 379M 371M 16.39B
Net income 24.55M 21.55M 19.84M 18.49M 34.87M 2.33B 35.58M 239M 92.46M 1.15B 92.18M 90.18M 3.99B 27.8M 24.41M 22.47M 20.94M 39.48M 2.64B 40.28M 270M 105M 1.3B 104M 102M 4.52B
Net Debt - -
Logo IRADIMED CORPORATION
IRadimed Corporation develops, manufactures, markets and distributes magnetic resonance imaging (MRI) compatible medical devices and accessories, disposables and services. Its MRidium 3870 MRI Compatible IV infusion pump system provides a non-magnetic Intravenous (IV) infusion pump system that is specifically designed for safe use during MRI procedures. Its MRidium 3860+ MRI Compatible IV infusion pump system has been designed with a non-magnetic ultrasonic motor with non-ferrous parts and other special features to safely and predictably and other IV fluids during various MRI procedures. Its IRadimed 3880 MRI Compatible patient vital signs monitoring system has been designed with non-magnetic components and other features to safely and accurately during various MRI procedures. The Company sells its products primarily to hospitals and acute care facilities. The IRADIMED 3880 system operates dependably on magnetic fields of over 30,000 gauss.
Employees
166
Date Price Change Volume
01/07/26 US$98.88 +3.47% 85,496
30/06/26 US$95.56 +1.58% 109,602
29/06/26 US$94.07 +0.12% 104,749
26/06/26 US$93.96 +0.10% 322,740
25/06/26 US$93.87 -0.83% 98,588
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
95.56USD
Average target price
118.00USD
Spread / Average Target
+23.48%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. IRMD Stock